Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and dna flow cytometry

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Cancer

• Publication date

  1990-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19900501)63:9<1761::AID-CNCR2820630918>3.0.CO;2-3PMID 2649227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Steroid receptors in breast cancer: Sources of inter-laboratory variation in dextran-charcoal assays

  2005cited by this paper
• Prognostic significance of steroid hormone receptors and histopathological characterization of human breast cancer

  2004cited by this paper
• Immunocytochemical detection of estrogen and progesterone receptors in 124 human breast cancers.

  1988cited by this paper
• Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity.

  1988cited by this paper
• Histopathologic characterization of human breast cancer in correlation with estrogen receptor status. A comparison of immunocytochemical and biochemical analysis

  1988cited by this paper
• Immunohistological demonstration of progesterone receptor in breast carcinomas: correlation with radioligand binding assays and oestrogen receptor immunohistology.

  1988cited by this paper
• Immunocytochemical detection of progesterone receptor in breast cancer with monoclonal antibody. Relation to biochemical assay, disease‐free survival, and clinical endocrine response

  1988cited by this paper
• Influence of endocrine status on biochemical and immunocytochemical estrogen and progesterone receptor assays in breast cancer patients

  1988cited by this paper
• Prognostic significance of the DNA content of human breast cancer

  1987cited by this paper
• Tumour DNA ploidy as an independent prognostic factor in breast cancer.

  1987cited by this paper
• Immunocytochemical study with monoclonal antibodies to progesterone receptor in human breast tumors.

  1987cited by this paper
• Multiple microsample analysis of intratumor estrogen receptor distribution in breast cancers by a combined biochemical/immunohistochemical method.

  1987cited by this paper
• Correlation of immunocytochemically demonstrated estrogen receptor distribution and histopathologic features in primary breast cancer.

  1987cited by this paper
• Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.

  1987cited by this paper
• Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer.

  1987cited by this paper
• Relationship between flow cytometric parameters, steroid receptors, and menopausal status in breast cancers.

  1987cited by this paper
• Proliferative index, cytosol estrogen receptor and axillary node status as prognostic predictors in human mammary carcinoma.

  1986cited by this paper
• Immunohistochemical measurement of estrogen receptors in breast cancer tissue samples.

  1986cited by this paper
• Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy.

  1986cited by this paper
• A proposed classification of breast cancer based on kinetic information derived from a comparison of risk factors in 168 primary operable breast cancers

  1986cited by this paper
• Estrogen and progesterone receptors in human breast cancer. Correlation with histologic subtype and degree of differentiation

  1986cited by this paper
• Immunocytochemical study of mammalian progesterone receptor using monoclonal antibodies.

  1985cited by this paper
• Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

  1985cited by this paper
• Molecular biology of human T-lymphotropic retroviruses.

  1985cited by this paper
• Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors.

  1985cited by this paper
• Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients.

  1985cited by this paper
• Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.

  1984cited by this paper
• A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis.

  1983cited by this paper
• [Correlation between morphology and steroid receptors in breast cancer].

  1983cited by this paper
• Monoclonal antibodies to rabbit progesterone receptor: crossreaction with other mammalian progesterone receptors.

  1983cited by this paper
• Oestrogen receptors in human breast cancer

  1982cited by this paper
• Hormone receptor levels related to histological parameters of tumor‐host relationships in female breast carcinoma

  1982cited by this paper
• Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer

  1980cited by this paper
• Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma

  1980cited by this paper
• Female sex steroid receptor status in primary and metastatic breast carcinoma and its relationship to serum steroid and peptide hormone levels

  1980cited by this paper
• Pathological review of breast lesions analyzed for estrogen receptor protein.

  1975cited by this paper
• Malignant and benign human mammary disease: Estrogen binding in relation to clinical data

  1974cited by this paper
• Statistical methods for rates and proportions

  1973cited by this paper
• Histological Grading and Prognosis in Breast Cancer

  1957cited by this paper

• A CROSS SECTIONAL STUDY OF BREAST CANCER HISTOMORPHOLOGY AND ITS CORRELATION WITH ER/PR, HER 2NEU AND KI-67 EXPRESSION IN A TERTIARY CARE HOSPITAL AT KANPUR

  2021cites this paper
• A colored view on quantitative pathology

  2017cites this paper
• Annexin A3 as a Prognostic Biomarker for Breast Cancer: A Retrospective Study

  2017cites this paper
• Morphological Profile and Hormone Receptor Status in Breast Carcinomas

  2017cites this paper
• Evaluation of Expression and Correlation of ER, PR and Ki 67 Tumor Markers in Breast Carcinoma

  2016cites this paper
• Preoperative Breast Cancer Evaluation and Advanced Breast Cancer Imaging

  2014cites this paper
• Östrogen- und Progesteronrezeptoren sowie Her2

  2013cites this paper
• STEROID RECEPTOR EXPRESSION IN DIAGNOSIS AND PROGNOSIS OF LIBYAN BREAST CANCER by

  2012cites this paper
• Special Types of Breast Carcinoma

  2012cites this paper
• Quantitative assessment and classification of tissue-based biomarker expression with color content analysis.

  2012cites this paper
• Prognostic Significance of Angiogenesis by Chalkley Counting in Node Negative Cancer of the Ampulla of Vater

  2012cites this paper
• Estrogen receptor, progesterone receptor, and nuclear size features in female breast cancer in Libya: correlation with clinical features and survival.

  2012cites this paper
• Genomic alterations and phenotype of large compared to small high-grade ductal carcinoma in situ.

  2011cites this paper
• The Progression of Pre-invasive to Invasive Cancer

  2011cites this paper
• Estrogen receptor alpha, estrogen receptor beta, and progesterone receptor as possible prognostic factor in radically resected gallbladder carcinoma.

  2009cites this paper
• Automated Quantitative Assessment of HER-2/neu Immunohistochemical Expression in Breast Cancer

  2009cites this paper
• Triple-Negative Breast Cancer and Obesity in a Rural Appalachian Population

  2008influential citation
• Hyperplastic and Neoplastic Lesions of the Mammary Gland in Macaques

  2006cites this paper
• Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer

  2005cites this paper
• Estrogen and progesterone receptors in breast cancer– the current state of knowledge

  2005cites this paper
• Expression of E26 transformation specific (ETS-1) related to angiogenesis in ovarian endometriosis.

  2004cites this paper
• Frequent amplification and overexpression of CCND1 in male breast cancer

  2004cites this paper
• Estrogen receptor mutations in human disease.

  2004cites this paper
• REVIEW Ductal Carcinoma In Situ, Complexities and Challenges

  2004cites this paper
• The relationship of estrogen receptor status to DNA ploidy in breast cancer

  2004cites this paper
• The detection and analysis of estrogen and progesterone receptors in breast cancer (report of 1,393 patients)

  2004cites this paper
• Ductal carcinoma in situ, complexities and challenges.

  2004cites this paper
• Molecular Evolutionary Patterns in Breast Cancer

  2003cites this paper
• Molecular diagnostics for determination of HER2 status in breast cancer

  2003cites this paper
• The clinical evaluation of HER‐2 status: which test to use?

  2003cites this paper
• What the clinician needs from the pathologist: evidence-based reporting in breast cancer.

  2001cites this paper
• Evaluating HER2 amplification and overexpression in breast cancer

  2001cites this paper
• Carcinoma mucinoso de la mama: características clínicas, biológicas y pronósticas en comparación con las del ductal infiltrante de tipo clásico

  2001cites this paper
• Histological and biological evolution of human premalignant breast disease.

  2001cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper
• Ductal carcinoma in situ. Implications for screening mammography.

  2000cites this paper
• Androgen sensitivity of prostate cancer: special reference to prognostic factors and androgen receptor

  2000cites this paper
• Ductal carcinoma in situ. Implications for screening mammography.

  2000cites this paper
• Part III. The pathobiology of ductal carcinoma in situ.

  2000cites this paper
• Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer.

  2000cites this paper
• Androgen Sensitivity of Prostate Cancer

  2000cites this paper
• Biological Features of Premalignant Disease in the Human Breast

  2000cites this paper
• Frequent Amplification of Chromosomal Region 20 q 12-q 13 in Ovarian Cancer 1

  2000cites this paper
• Androgen receptor gene amplification increases tissue PSA protein expression in hormone‐refractory prostate carcinoma

  1999cites this paper
• Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion

  1999cites this paper
• Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.

  1999cites this paper
• Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas.

  1999cites this paper
• Apoptosis during breast carcinoma progression.

  1999cites this paper
• Regulation of vascular endothelial growth factor secretion in human meningioma cells.

  1999cites this paper
• Paraffin section immunocytochemistry and cytosol-based ligand-binding assays for ER and PR detection in breast cancer: the time has come for more objectivity.

  1998cites this paper
• Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in invasive ductal carcinoma of the breast in Taiwan.

  1998cites this paper
• Low biologic aggressiveness in breast cancer in women using hormone replacement therapy.

  1998cites this paper
• Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia.

  1998cites this paper
• Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma.

  1997cites this paper
• Medullary Carcinoma of the Breast

  1997cites this paper
• [Value of detection of hormone receptors by biochemical and immunochemical methods in therapeutic decision for breast cancer].

  1996cites this paper
• Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early‐stage breast carcinomas: Prognostic significance

  1996cites this paper
• Immunohistochemical detection of oestrogen receptors in ductal carcinoma in situ of the breast.

  1996cites this paper
• Comparison of two monoclonal antibodies for the detection of estrogen receptors in primary breast carcinomas.

  1996cites this paper
• A colored view on quantitative pathology: aspects of true color image analysis in routine pathology

  1996cites this paper
• A colored view on quantitative pathology

  1996cites this paper
• The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters.

  1996cites this paper
• Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material: Correlations between flow cytometric, clinical, and pathologic variables

  1996cites this paper
• Biological Staging of Incipient, in Situ, and Invasive Breast Carcinomas a

  1996cites this paper
• [Biochemical basis for detection of estrogen and progesterone receptors in breast tumors using immunohistochemistry].

  1996cites this paper
• Variations in steroid hormone receptor content throughout age and menopausal periods, and menstrual cycle in breast cancer patients.

  1996cites this paper
• Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material. Correlations between flow cytometric, clinical, and pathologic variables. MMMCP Collaborative Group. Multicenter Morphometric Mammary Carcinoma Project Collaborative Group.

  1996cites this paper
• Multicentric breast carcinoma: Evaluation of clinicopathological and immunohistochemical characteristics

  1996cites this paper
• [Breast cancer: comparison between biochemical and immunohistochemical determination of estrogen receptors].

  1996cites this paper
• Application of quantitative analysis to biologic profile evaluation in breast cancer

  1995cites this paper
• Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer.

  1995cites this paper
• Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications.

  1995cites this paper
• Production and application of mouse antiserum to human estrogen receptors

  1995cites this paper
• Proteinase activity in invasive cancer of the breast. Correlation with tumor progression.

  1995cites this paper
• [Gallbladder cancer: immunohistochemical expression of the protein related to estrogen receptor (p29) and of the protein induced by estrogen (pS2)].

  1995cites this paper
• [Expression of p29, estrogen receptor related protein in primary breast carcinoma. Methodological, anatomoclinical, and DNA content analysis].

  1994cites this paper
• Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States)

  1994cites this paper
• Determination of estrogen receptors in paraffin‐embedded tissue: Techniques and the value in breast cancer treatment

  1994cites this paper
• Detection of steroid receptors in breast cancer: relationship between EIA and IHC methods.

  1994cites this paper
• Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features.

  1993cites this paper
• Immunohistochemical Detection of Female Sex Hormone Receptors in Meningiomas

  1993cites this paper
• Immunohistochemical determination of estrogen and progesterone receptors and DNA flow cytometry in endometrial cancer

  1993cites this paper
• DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients

  1993cites this paper
• Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors

  1993cites this paper
• The Significance of the Extracellular Matrix in Mammary Epithelial Carcinogenesis

  1993cites this paper
• Ductal carcinoma of breast: nuclear grade as a predictor of S-phase fraction.

  1993cites this paper
• Immunohistochemical determination of estrogen and progesterone receptor status in breast cancer.

  1993cites this paper
• Comparison of classic and quantitative prognostic factors in hormone receptor-positive and hormone receptor-negative female breast cancer.

  1993cites this paper
• Determination of Estrogen Receptors in Paraffin-Embedded Tissue: Techniques and the value in breast cancer treatment

  1992cites this paper
• Sex steroid receptors, S-phase fraction and DNA ploidy as determinants of the risk of relapse and death of female breast cancer.

  1992cites this paper
• Hormone receptors in malignancy.

  1992cites this paper
• Altering cell kinetics with endocrine therapy.

  1992cites this paper
• A simplified histoscore for the estrogen receptor assay in breast cancer.

  1992cites this paper
• Prognostic factors in breast-cancer (review).

  1992cites this paper
• Immunohistochemical demonstration of estrogen receptors on routine paraffin sections of breast carcinomas: a comparison with frozen sections and an enzyme immunoassay.

  1992cites this paper
• Immunohistochemical detection of estrogen receptors on paraffin sections of normal, hyperplatic and carcinomatous endometrium.

  1992cites this paper
• Outcome of conservative therapy for invasive breast cancer by histologic subtype.

  1992cites this paper
• Direct Gold-Silver Method for HCG Binding to Specific Tissue Structures

  1992cites this paper
• Quantitation of estrogen and progesterone receptors by immunocytochemical and image analyses

  1992cites this paper
• DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer

  1992cites this paper